{"title":"Classification of chemoradiotherapy sensitivity in hypopharyngeal squamous cell carcinoma based on deep-learning and radiomics feature fusion.","authors":"Hengmin Tao, Xinbo Yang, Meihui Chen, Baosheng Li","doi":"10.21037/tcr-2025-1628","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Analyzing apparent diffusion coefficient (ADC) images before chemoradiotherapy (CRT) can effectively predict the treatment response of patients with hypopharyngeal squamous cell carcinoma (HPSCC), thereby reducing the treatment risks. This study aimed to develop a predictive model by combining deep-learning features and radiomics features derived from ADC images to predict the CRT sensitivity of HPSCC patients, providing effective guidance for treatment strategy selection.</p><p><strong>Methods: </strong>This study retrospectively analyzed the data of 120 HPSCC patients. Deep-learning features were extracted from ADC images using a vision transformer (ViT)-based deep-learning model, while radiomics features were extracted using the PyRadiomics feature extractor. Among the 1,288 extracted radiomics features, the most significant ones were selected using the Spearman's correlation coefficient, intraclass correlation coefficient (ICC), and least absolute shrinkage and selection operator (LASSO) method. These features were fused through a concatenation approach, and a classification prediction was performed using a convolutional neural network with three fully connected layers.</p><p><strong>Results: </strong>The accuracy, sensitivity, specificity, and area under the curve (AUC) values of the feature fusion model were 0.99 <i>vs</i>. 0.875, 0.988 <i>vs</i>. 0.842, 1.000 <i>vs</i>. 1.000, and 1.000 <i>vs</i>. 0.947, for the training and validation datasets, respectively. The feature fusion model performed optimally in comparison to the other models. In the validation dataset, the accuracy of the feature fusion model improved by 16.7% and 4.2% compared to the clinical and radiomic models, respectively.</p><p><strong>Conclusions: </strong>The model developed in this study, which integrates deep-learning features with traditional radiomics features, can accurately predict the CRT sensitivity of HPSCC patients using pre-treatment ADC images. This model provides an effective reference for selecting optimal treatment strategies for patients.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 8","pages":"5142-5154"},"PeriodicalIF":1.7000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432764/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2025-1628","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Analyzing apparent diffusion coefficient (ADC) images before chemoradiotherapy (CRT) can effectively predict the treatment response of patients with hypopharyngeal squamous cell carcinoma (HPSCC), thereby reducing the treatment risks. This study aimed to develop a predictive model by combining deep-learning features and radiomics features derived from ADC images to predict the CRT sensitivity of HPSCC patients, providing effective guidance for treatment strategy selection.
Methods: This study retrospectively analyzed the data of 120 HPSCC patients. Deep-learning features were extracted from ADC images using a vision transformer (ViT)-based deep-learning model, while radiomics features were extracted using the PyRadiomics feature extractor. Among the 1,288 extracted radiomics features, the most significant ones were selected using the Spearman's correlation coefficient, intraclass correlation coefficient (ICC), and least absolute shrinkage and selection operator (LASSO) method. These features were fused through a concatenation approach, and a classification prediction was performed using a convolutional neural network with three fully connected layers.
Results: The accuracy, sensitivity, specificity, and area under the curve (AUC) values of the feature fusion model were 0.99 vs. 0.875, 0.988 vs. 0.842, 1.000 vs. 1.000, and 1.000 vs. 0.947, for the training and validation datasets, respectively. The feature fusion model performed optimally in comparison to the other models. In the validation dataset, the accuracy of the feature fusion model improved by 16.7% and 4.2% compared to the clinical and radiomic models, respectively.
Conclusions: The model developed in this study, which integrates deep-learning features with traditional radiomics features, can accurately predict the CRT sensitivity of HPSCC patients using pre-treatment ADC images. This model provides an effective reference for selecting optimal treatment strategies for patients.
背景:在放化疗(CRT)前分析表观扩散系数(ADC)图像可以有效预测下咽鳞状细胞癌(HPSCC)患者的治疗反应,从而降低治疗风险。本研究旨在结合ADC图像的深度学习特征和放射组学特征建立预测模型,预测HPSCC患者的CRT敏感性,为治疗策略的选择提供有效的指导。方法:回顾性分析120例HPSCC患者的资料。使用基于视觉转换器(vision transformer, ViT)的深度学习模型提取ADC图像的深度学习特征,使用PyRadiomics特征提取器提取放射组学特征。在提取的1288个放射组学特征中,使用Spearman相关系数、类内相关系数(ICC)和最小绝对收缩和选择算子(LASSO)方法选择最显著的特征。通过串联方法融合这些特征,并使用具有三个完全连接层的卷积神经网络进行分类预测。结果:特征融合模型在训练集和验证集上的准确率、灵敏度、特异性和曲线下面积(AUC)值分别为0.99 vs 0.875、0.988 vs 0.842、1.000 vs 1.000、1.000 vs 0.947。与其他模型相比,特征融合模型表现最佳。在验证数据集中,与临床和放射学模型相比,特征融合模型的准确率分别提高了16.7%和4.2%。结论:本研究建立的模型将深度学习特征与传统放射组学特征相结合,可以通过治疗前ADC图像准确预测HPSCC患者的CRT敏感性。该模型为患者选择最优治疗策略提供了有效参考。
期刊介绍:
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.